Search Results1-5 of  5

  • KANZAKI Mirei ID: 9000002043252

    Department of Immunology, Faculty of Medicine, University of Yamanashi (2007 from CiNii)

    Articles in CiNii:1

    • TGF-β type I receptor kinase inhibitor down-regulates rheumatoid synoviocytes and prevents the arthritis induced by type II collagen antibody (2007)
  • KANZAKI Mirei ID: 9000002063045

    Department of Dermatology, Faculty of Medicine, University of Yamanashi (2011 from CiNii)

    Articles in CiNii:3

    • Complete remission of a primary cutaneous follicle-center cell lymphoma (EORTC criteria)/diffuse large B-cell lymphoma (WHO criteria) by single first-line therapy with rituximab (2006)
    • A novel immunotherapeutic approach to melanoma-bearing hosts with protein-transduction domain-containing immunogenic foreign antigens (2010)
    • Novel immunotherapeutic approaches to skin cancer treatments using protein transduction technology (2011)
  • KANZAKI Mirei ID: 9000002141416

    Articles in CiNii:6

    • Eight Cases of Drug Eruption Due to Itraconazole Pulse Therapy (2008)
    • 横紋筋融解症を来した true histiocytic lymphoma の1例 (2004)
    • 超音波メスによる難治性尋常性疣贅の治療 (特集 最近のトピックス 2005 Clinical Dermatology 2005) -- (皮膚疾患治療のポイント) (2005)
  • KANZAKI Mirei ID: 9000283320941

    Departments of Dermatology, Mito Saiseikai General Hospital (2015 from CiNii)

    Articles in CiNii:1

    • A case of primary apocrine carcinoma with neuroendocrine differentiation occurring on the right parasternal region (2015)
  • Kanzaki Mirei ID: 9000273008009

    Department of Dermatology, Faculty of Medicine, University of Yamanashi (2008 from CiNii)

    Articles in CiNii:1

    • Eight Cases of Drug Eruption Due to Itraconazole Pulse Therapy (2008)
Page Top